Hate the Game, Not the Player? – Mylan Is Out of Tune Amid An Angry Chorus

(This is an excerpt from an article I originally published on Seeking Alpha on August 29, 2016. Click here to read the entire piece.) This is the message actress Sarah Jessica Parker posted on Instagram Thursday, August 25, 2016 to join a chorus of protest and complaint about the extremely high cost of the EpiPen® … Read more

Key Lessons from the Brazil ETF Trade

Back in October, 2009 When Brazil won the 2016 Summer Olympics, I heralded the news as an opportunity to invest in a country that promised to grow faster than the United States. The iShares MSCI Brazil Capped (EWZ) never quite matched its peak from 2008 but managed to ride the wave of a post-recession, commodity … Read more

Hillary Clinton Takes Down the iShares Nasdaq Biotechnology: Buy the News?

The shot was heard around the world of biotech: Price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on. -H https://t.co/9Z0Aw7aI6h — Hillary Clinton (@HillaryClinton) September 21, 2015 The reaction was immediate and sharp for iShares Nasdaq Biotechnology (IBB) as it lost 4.6% on … Read more

The (Limited?) Opportunity for Regulatory Renewal

The never-ending debate about government regulations has recently inherited an intriguing level of urgency with the economy stalled and both major political parties targeting regulations as potential impediments to growth. The Obama administration announced plans to remove regulations that it estimated would save businesses $5 billion over five years. In an all too predictable partisan … Read more